Bastiano Sanna
PROFESSIONAL EXPERIENCE
Bastiano Sanna is Industrial Partner of FSI. Bastiano has a solid experience in the Pharmaceuticals industry at international level, particularly in the US where he developed his entire career, from 2003 until his return to Italy last May.
From 2020 to May 2024 he worked at Vertex [VRTX] a global leader in the research, development and commercialisation of micromolecular drugs mainly for the treatment of cancer, viral, inflammatory and autoimmune diseases. At Vertex, he was Executive Vice President and Head of Cell and Genetic Therapies and coordinated the Jeffrey Leiden Center for Cell and Genetic Therapies in Boston.
From 2018 to 2020, he was CEO of Semma Therapeutics, a company dedicated to the development of cell therapies for people with diabetes.
From 2016 to 2018, as Chief Operating Officer of Magenta Therapeutics he was responsible for operations, finance, clinical development and program management.
From 2010 to 2016, he was part of the leadership team of Novartis’ Cell and Gene Therapy Unit as Global Head of Stem Cell Transplantation and Initial Programs and was globally responsible for strategic planning and portfolio management at Novartis Institutes for BioMedical Research.
EDUCATION
Sanna received a Ph.D. in biotechnology from the University of Sassari, in Italy.